Feminizing Hormone Therapy and Subclinical Indicators of CVD Risk in Transgender Women With HIV

被引:0
|
作者
Nogueira, Nicholas Fonseca
Salazar, Ana S.
Ma Ruixuan
Aguilar, Natalie
Gonzalez, Alex
Porras, Valeria
Parker, Meela
Mantero, Alejandro
Hurwitz, Barry E.
Alcaide, Maria L.
Martinez, Claudia
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A14353
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks
    Sudhakar, Deepshika
    Huang, Zhong
    Zietkowski, Maeson
    Powell, Natasha
    Fisher, Andrew R.
    NEUROUROLOGY AND URODYNAMICS, 2023, 42 (05) : 903 - 920
  • [32] Relationship Between Serum Estradiol Concentrations and Clinical Outcomes in Transgender Individuals Undergoing Feminizing Hormone Therapy: A Narrative Review
    Nolan, Brendan J.
    Cheung, Ada S.
    TRANSGENDER HEALTH, 2021, 6 (03) : 125 - 131
  • [33] Addition of progesterone to feminizing gender-affirming hormone therapy in transgender individuals for breast development: a randomized controlled trial
    Benthe A.M. Dijkman
    Danithsia Helder
    Lidewij S. Boogers
    Noor C. Gieles
    Jason O. van Heesewijk
    Sjoerd te Slaa
    Niels P.T.J. Liberton
    Chantal M. Wiepjes
    Christel J.M. de Blok
    Martin den Heijer
    Koen M.A. Dreijerink
    BMC Pharmacology and Toxicology, 24
  • [34] Menopausal hormone therapy for women living with HIV
    King, Elizabeth Marie
    Prior, Jerilynn C.
    Pick, Neora
    van Schalkwyk, Julie
    Kestler, Mary
    Tkachuk, Stacey
    Loutfy, Mona
    Murray, Melanie C. M.
    LANCET HIV, 2021, 8 (09): : E591 - E598
  • [35] Characterization of Behavioral and Clinical Risk Factors for HIV Risk Among Transgender Women
    Wansom, Tanyaporn
    Sacdalan, Carlo
    Ratnaratorn, Nisakorn
    Kroon, Eugene
    Teeratakulpisarn, Nipat
    O'Connell, Robert J.
    Michael, Nelson L.
    Robb, Merlin L.
    Ananworanich, Jintanat
    Vasan, Sandhya
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 147 - 147
  • [36] Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy
    Greene, Dina N.
    Schmidt, Robert L.
    McPherson, Gabrielle Winston
    Rongitsch, Jessica
    Imborek, Katherine L.
    Dickerson, Jane A.
    Drees, Julia C.
    Humble, Robert M.
    Nisly, Nicole
    Dole, Nancy J.
    Dane, Susan K.
    Frerichs, Janice
    Krasowski, Matthew D.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2021, 6 (01): : 15 - 26
  • [37] DESCRIBING TRENDS IN THE PROSTATE OF TRANSGENDER WOMEN ON ANDROGEN DEPRIVATION HORMONE THERAPY
    Yatsenko, Tatyana
    Celtik, Kenan
    Lundon, Dara
    Zisman, Ariel
    Djordjevic, Miroslav
    Purohit, Rajveer
    JOURNAL OF UROLOGY, 2023, 209 : E18 - E18
  • [38] Low total motile sperm in transgender women seeking hormone therapy
    Marsh, Courtney
    McCracken, Megan
    Gray, Meredith
    Nangia, Ajay
    Gay, Judy
    Roby, Katherine F.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2019, 36 (08) : 1639 - 1648
  • [39] Low total motile sperm in transgender women seeking hormone therapy
    Courtney Marsh
    Megan McCracken
    Meredith Gray
    Ajay Nangia
    Judy Gay
    Katherine F. Roby
    Journal of Assisted Reproduction and Genetics, 2019, 36 : 1639 - 1648
  • [40] The Effects of Exercise Therapy on CVD Risk Factors in Women
    Hur, Sun
    Kim, Seon-Rye
    JOURNAL OF PHYSICAL THERAPY SCIENCE, 2014, 26 (09) : 1367 - 1370